Class notes
Cursus reumatologie
- Course
- Institution
reumatologische aandoeningen - cursus REVAKI UGent
[Show more]
2 reviews
By: revaki • 8 months ago
Binge tissue disorders and CFS are missing, otherwise an excellent summary!
By: fienmatthijs13 • 11 months ago
Seller
Follow
ScientiaMedica
Reviews received
Content preview
2021Revalidatie en kinesitherapie bij
reumatologische aandoeningen
3DE BACHELOR REVALIDATIEWETENSCHAPPEN EN KINESITHERAPIE
UGENT
STIJN DEBUF
,REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
Revalidatie bij reumatologische aandoeningen
3de bachelor Revalidatiewetenschappen en Kinesitherapie – Universiteit Gent
1
,REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
INHOUDSTAFEL
Hoofdstuk 1 ....................................................................................................................................................................................... 6
Inleiding reumatologische aandoeningen en bindweefselziekten................................................................. 6
Reumatische systeemziekten of bindweefselziekten .................................................................................... 9
Systeemlupus .................................................................................................................................................. 9
Sjögren syndroom ......................................................................................................................................... 11
Polymyalgia reumatica .................................................................................................................................. 12
Idiopathische inflammatoire myositis ........................................................................................................... 13
Systeemsclerose ............................................................................................................................................ 14
Neoplasie – oncologie in de reumatologie .................................................................................................. 17
Bottumoren ................................................................................................................................................... 17
Paraneoplastische syndromen ...................................................................................................................... 19
Voorbeeldcasussen ....................................................................................................................................... 21
Hoofdstuk 2 ..................................................................................................................................................................................... 23
Osteoartritis (OA) ....................................................................................................................................... 23
Etiologie (OA) ................................................................................................................................................ 23
Epidemiologie en risicofactoren (OA) ........................................................................................................... 27
Diagnostiek (OA) ........................................................................................................................................... 28
Subtypes (OA)................................................................................................................................................ 30
Medische behandeling (OA) .......................................................................................................................... 32
Revalidatie (OA) ............................................................................................................................................ 35
Hoofdstuk 3 ..................................................................................................................................................................................... 49
Reumatoïde artritis (RA) ............................................................................................................................. 49
Inleiding (RA) ................................................................................................................................................. 49
Klinische manifestaties (RA) .......................................................................................................................... 49
Etiologie (RA) ................................................................................................................................................. 52
Diagnose (RA) ................................................................................................................................................ 53
Medische behandeling (RA) .......................................................................................................................... 58
Septische artritis (SA) ................................................................................................................................. 62
Inleiding (SA) ................................................................................................................................................. 62
Etiologie (SA) ................................................................................................................................................. 62
Diagnose (SA) ................................................................................................................................................ 63
Medische behandeling (SA)........................................................................................................................... 64
Kristalartritis (KA) ....................................................................................................................................... 66
Inleiding (KA) ................................................................................................................................................. 66
Etiologie JICHT ............................................................................................................................................... 66
2
, REUMATOLOGIE – 3DE BACHELOR REVAKI UGENT
Prevalentie JICHT........................................................................................................................................... 67
Diagnose JICHT .............................................................................................................................................. 67
Medische behandeling JICHT ........................................................................................................................ 68
Etiologie PSEUDOJICHT ................................................................................................................................. 69
Diagnose PSEUDOJICHT................................................................................................................................. 69
Medische behandeling PSEUDOJICHT ........................................................................................................... 70
Hoofdstuk 4 ..................................................................................................................................................................................... 71
Avasculaire necrose (aseptische necrose) ................................................................................................... 71
Inleiding ......................................................................................................................................................... 71
Symptomen ................................................................................................................................................... 72
Diagnostiek.................................................................................................................................................... 73
Oorzaken ....................................................................................................................................................... 76
Medische behandeling .................................................................................................................................. 78
Revalidatie ..................................................................................................................................................... 79
Hoofdstuk 5 ..................................................................................................................................................................................... 81
Abarticulaire klachten ................................................................................................................................ 81
Inleiding ......................................................................................................................................................... 81
Periartritis scapulohumeralis (PSH) ............................................................................................................... 81
Carpaaltunnel syndroom (CTS) ..................................................................................................................... 84
Kniekuilcyste (Baker’s Cyst) ........................................................................................................................... 86
Hoofdstuk 6 ..................................................................................................................................................................................... 88
Osteoporose ............................................................................................................................................... 88
Inleiding ......................................................................................................................................................... 88
Symptomatologie .......................................................................................................................................... 89
Diagnose ........................................................................................................................................................ 91
Pathogenese.................................................................................................................................................. 94
Preventie en therapie.................................................................................................................................... 96
Revalidatie bij osteoporose ......................................................................................................................... 104
Hoofdstuk 7 .................................................................................................................................................................................. 113
Spondyloartritis (SpA) .............................................................................................................................. 113
Inleiding SpA................................................................................................................................................ 113
Concept SpA ................................................................................................................................................ 119
Prevalentie SpA ........................................................................................................................................... 120
Algemene kenmerken SpA .......................................................................................................................... 121
Specifieke ziektebeelden SpA ..................................................................................................................... 128
Patient-partner program SpA ...................................................................................................................... 145
Revalidatie SpA............................................................................................................................................ 146
3
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller ScientiaMedica. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $6.43. You're not tied to anything after your purchase.
Can Stuvia be trusted?
4.6 stars on Google & Trustpilot (+1000 reviews)
67474 documents were sold in the last 30 days
Founded in 2010, the go-to place to buy study notes for 14 years now